Nessus
Security scanner operated by Tenable
Tenable
Operator
See operator's docs
Verification
Nessus
robots.txt token
No
Honours robots.txt
What Nessus is
Nessus vulnerability scanner.
Its robots.txt token is Nessus , but it is not listed as honouring robots.txt. Operator documentation: Tenable .
Verifying it yourself
WebDecoy has no published IP list or reverse DNS hostname on file for Nessus. Check Tenable's documentation for one, such as a list of addresses or signed requests. Until you can check the source address, the User-Agent is only a claim, and copying a User-Agent costs nothing.
Blocking it
You can ask in robots.txt, but it is not listed as honouring it:
User-agent: Nessus
Disallow: /robots.txt only works on a client willing to obey it, which rules out every request that was already lying about who it is. Stopping those takes enforcement at the network or application layer, keyed on something the client cannot simply retype. That is the problem WebDecoy exists to solve.
Frequently Asked Questions
What is Nessus? +
Nessus is a security scanner operated by Tenable. Nessus vulnerability scanner.
How do I verify Nessus? +
WebDecoy has no published IP list or reverse DNS hostname on file for Nessus. Check Tenable's documentation for one; until you can check the source address, the User-Agent is only a claim.
How do I block Nessus? +
It is not listed as honouring robots.txt, so a Disallow rule for Nessus may be ignored. Block it at your firewall, CDN or application instead, after verifying which requests really come from Tenable.
Related crawlers
- Acunetix Invicti
- Burp Suite PortSwigger
- Censys Censys
- Cloudflare Security Center Cloudflare
- Detectify Detectify
- Intruder Intruder
- Netsparker Invicti
- Nuclei ProjectDiscovery
- OWASP ZAP OWASP
- Palo Alto Networks Cortex Xpanse Palo Alto Networks
- Qualys Qualys
- Recorded Future Crawler Recorded Future
See which Nessus requests are real
WebDecoy verifies declared crawlers against what their operators publish and identifies the ones that fail, as persistent actors rather than disposable IPs.